 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > American Biogenetic Sciences, Inc.
 |
American Biogenetic Sciences, Inc. |
 |
 |
 |
PROFILE |
 |
Even mice can do their part to fight disease. With the help of an antigen-free mouse colony, American Biogenetic Sciences has developed monoclonal antibodies used for tests that diagnose blood clots lodged in the legs and lungs, a sometimes fatal condition known as thrombosis. American Biogenetic Sciences is also developing therapies for epilepsy, migraines, Alzheimer's and Parkinson's diseases, and other disorders. Its Global Scientific Network conducts research through coordinators in China, Germany, Ireland, and Russia. Chairman Alfred Roach owns about 25% of the firm, which sold subsidiary Stellar Bio Systems, which markets in vitro diagnostic products that detect infectious and autoimmune diseases.
COMPETITION |
 |
Axis-Shield Plc (ASD)
PharmaNetics, Inc. (PHAR)
Xtrana, Inc. (XTRN)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 2.30
1-Yr. Sales Growth: 64.3%
Employees: 33
Revenue per employee: $69,696.97
KEY PEOPLE |
 |
Alfred J. Roach
CEO
CONTACT INFO |
 |
1375 Akron St.
Copiague, NY 11726
US
Phone: 631-789-2600
Fax: 631-789-1661
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |